Weihua Guo

1.2k total citations
46 papers, 653 citations indexed

About

Weihua Guo is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Weihua Guo has authored 46 papers receiving a total of 653 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 12 papers in Pulmonary and Respiratory Medicine and 10 papers in Immunology. Recurrent topics in Weihua Guo's work include Cancer Immunotherapy and Biomarkers (11 papers), Advanced Breast Cancer Therapies (5 papers) and MRI in cancer diagnosis (4 papers). Weihua Guo is often cited by papers focused on Cancer Immunotherapy and Biomarkers (11 papers), Advanced Breast Cancer Therapies (5 papers) and MRI in cancer diagnosis (4 papers). Weihua Guo collaborates with scholars based in China, United States and France. Weihua Guo's co-authors include Peter P. Lee, Colt A. Egelston, Yuan Yuan, James Waisman, Jin Sun Lee, Paul Frankel, Daniel Schmolze, Susan E. Yost, Lu Yu and Zhiyong Zhang and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Weihua Guo

44 papers receiving 648 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weihua Guo China 15 263 144 136 118 114 46 653
Mona Mustafa Germany 13 323 1.2× 229 1.6× 93 0.7× 63 0.5× 67 0.6× 25 861
Takashi Kasahara Japan 18 170 0.6× 268 1.9× 214 1.6× 140 1.2× 101 0.9× 65 941
Jian Xie China 16 181 0.7× 122 0.8× 95 0.7× 137 1.2× 55 0.5× 48 591
Yitao Mao China 18 110 0.4× 351 2.4× 84 0.6× 49 0.4× 238 2.1× 44 764
Man Liu China 14 287 1.1× 375 2.6× 89 0.7× 181 1.5× 143 1.3× 43 825
Ursula Kohlhofer Germany 16 150 0.6× 225 1.6× 61 0.4× 86 0.7× 97 0.9× 30 663
Hongmei Shen China 16 236 0.9× 433 3.0× 152 1.1× 207 1.8× 83 0.7× 37 1.0k
Joachim Reischl Germany 13 135 0.5× 315 2.2× 61 0.4× 170 1.4× 70 0.6× 26 731
Ciara O’Brien United Kingdom 15 241 0.9× 149 1.0× 118 0.9× 33 0.3× 81 0.7× 40 754
Prodipto Pal Canada 17 248 0.9× 306 2.1× 388 2.9× 52 0.4× 166 1.5× 49 956

Countries citing papers authored by Weihua Guo

Since Specialization
Citations

This map shows the geographic impact of Weihua Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weihua Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weihua Guo more than expected).

Fields of papers citing papers by Weihua Guo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weihua Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weihua Guo. The network helps show where Weihua Guo may publish in the future.

Co-authorship network of co-authors of Weihua Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Weihua Guo. A scholar is included among the top collaborators of Weihua Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weihua Guo. Weihua Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Xinyu, et al.. (2025). Deficiency of Cartilage‐Specific Y‐Box Binding Protein 1 Represses NFκB Signaling and Alleviates Osteoarthritis Progression. Arthritis & Rheumatology. 78(1). 90–104. 1 indexed citations
2.
Wang, Lei, Weihua Guo, Jiangnan Yu, et al.. (2024). PD-L1-expressing tumor-associated macrophages are immunostimulatory and associate with good clinical outcome in human breast cancer. Cell Reports Medicine. 5(2). 101420–101420. 46 indexed citations
3.
Egelston, Colt A., Weihua Guo, Diana L. Simons, et al.. (2024). Organ-Specific Immune Setpoints Underlie Divergent Immune Profiles across Metastatic Sites in Breast Cancer. Cancer Immunology Research. 12(11). 1559–1573. 2 indexed citations
4.
Li, Xinyu, et al.. (2024). Dipeptidyl Peptidase 4 (DPP4) Exacerbates Osteoarthritis Progression in an Enzyme‐Independent Manner. Advanced Science. 12(6). e2410525–e2410525. 3 indexed citations
5.
Guo, Weihua, Jiayi Tan, Lei Wang, et al.. (2024). Tumor draining lymph nodes connected to cold triple-negative breast cancers are characterized by Th2-associated microenvironment. Nature Communications. 15(1). 8592–8592. 5 indexed citations
6.
Shi, Guang‐Xia, Yu Wang, Zhaohui Zhang, et al.. (2024). Effect of acupuncture on quality of life in atrial fibrillation: study protocol for a randomised controlled trial. BMJ Open. 14(11). e087460–e087460.
7.
Guo, Weihua, Colt A. Egelston, Diana L. Simons, et al.. (2024). Tumor heterogeneity and clinically invisible micrometastases in metastatic breast cancer—a call for enhanced surveillance strategies. npj Precision Oncology. 8(1). 81–81. 4 indexed citations
8.
Li, Xinyu, et al.. (2024). Enhancing GFPT1 expression with glutamine protects chondrocytes in osteoarthritis. International Immunopharmacology. 143(Pt 2). 113427–113427. 2 indexed citations
9.
Dong, Yuqing, et al.. (2023). CXCL1 promoted the migration and invasion abilities of oral cancer cells and might serve as a promising marker of prognosis in tongue cancer. Journal of Oral Pathology and Medicine. 52(7). 583–592. 8 indexed citations
10.
Huang, Zeyu, Weihua Guo, & John T. Martin. (2023). Socioeconomic status, mental health, and nutrition are the principal traits for low back pain phenotyping: Data from the osteoarthritis initiative. JOR Spine. 6(2). e1248–e1248. 7 indexed citations
11.
Egelston, Colt A., Weihua Guo, Susan E. Yost, et al.. (2023). Immunogenicity and efficacy of pembrolizumab and doxorubicin in a phase I trial for patients with metastatic triple-negative breast cancer. Cancer Immunology Immunotherapy. 72(9). 3013–3027. 14 indexed citations
12.
Ye, Jian, Weihua Guo, Chongkai Wang, et al.. (2023). Peritumoral Immune-suppressive Mechanisms Impede Intratumoral Lymphocyte Infiltration into Colorectal Cancer Liver versus Lung Metastases. Cancer Research Communications. 3(10). 2082–2095. 6 indexed citations
13.
Chen, Peipei, et al.. (2023). Dynamic contrast-enhanced magnetic resonance imaging features and apparent diffusion coefficient value of HER2-positive/HR-negative breast carcinoma. Quantitative Imaging in Medicine and Surgery. 13(8). 4816–4825. 7 indexed citations
14.
Lee, Jin Sun, Susan E. Yost, Sierra Min Li, et al.. (2022). Genomic Markers of CDK 4/6 Inhibitor Resistance in Hormone Receptor Positive Metastatic Breast Cancer. Cancers. 14(13). 3159–3159. 16 indexed citations
15.
Egelston, Colt A., Weihua Guo, Jiayi Tan, et al.. (2022). Tumor-infiltrating exhausted CD8+ T cells dictate reduced survival in premenopausal estrogen receptor–positive breast cancer. JCI Insight. 7(3). 25 indexed citations
16.
Guo, Weihua, et al.. (2019). Diagnostic performance of minimum apparent diffusion coefficient value in differentiating the invasive breast cancer and ductal carcinoma in situ. Journal of Cancer Research and Therapeutics. 15(4). 871–871. 7 indexed citations
17.
18.
Liu, Cheng, et al.. (2015). CT virtual endoscopy for analyzing variations in the hepatic portal vein. Surgical and Radiologic Anatomy. 37(5). 457–462. 5 indexed citations
19.
Li, Kun, Feng Li, Lijuan Guo, et al.. (2013). [Increased survival of free fat grafts with adipose-derived stem cells and platelet-rich plasma in nude mice].. PubMed. 44(3). 337–41. 1 indexed citations
20.
Yang, Xiao‐Juan, Wei Jing, Weihua Guo, et al.. (2013). Adipogenic and osteogenic differentiation of Lin−CD271+Sca-1+ adipose-derived stem cells. Molecular and Cellular Biochemistry. 377(1-2). 107–119. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026